CNI-1493 for Treatment of Moderate to Severe Crohn's Disease

NCT00038766 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

33

Enrollment

INDUSTRY

Sponsor class

Stopped Unable to enroll into study.

Conditions

Crohn Disease

Interventions

DRUG: semapimod
DRUG: semapimod
DRUG: placebo

Sponsor

Ferring Pharmaceuticals